Anti-cancer cytotoxic effects of multiwalled carbon nanotubes

Current Pharmaceutical Design

Volumn 21, Issue 15, 2015, Pages 1920-1929

  García Hevia, Lorena ^a   Valiente, Rafael ^a   González, Jesús ^b   Fernández Luna, José Luís ^c   Villegas, Juan C ^d   Fanarraga, Mónica L ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b CITIMAC   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d Cardenal Herrera Oria   (Spain)

Author keywords

Cell death; Chemotherapy; Microtubule dynamics; MWCNTs; Tubulin

Indexed keywords

MULTI WALLED NANOTUBE; NANOMATERIAL; PACLITAXEL; TUBULIN; ANTINEOPLASTIC AGENT; CARBON NANOTUBE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER RESISTANCE; DRUG CYTOTOXICITY; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTUBULE; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; HUMANS; MICROTUBULES; NANOTUBES, CARBON; NEOPLASMS;

EID: 84928966763     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150302144101     Document Type: Article

References (110)

1. Eaton SL, Roche SL, Llavero-Hurtado M, et al. Total protein analysis as a reliable loading control for quantitative fluorescent Western blotting. PLoS One 2013; 8: e72457.
2. Fletcher DA, Mullins D. Cell mechanics and the cytoskele- ton. Nature 2010; 463: 485-92.
3. Mitchison T, Kirschner M. Dynamic instability of microtubule growth. Nature 1984; 312: 237-42.
4. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003; 112: 453-65.
5. Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 1998; 1: 123-30
6. Zhou J, Giannakakou P. Targeting microtubules for cancer chemo- therapy. Curr Med Chem Anti-Cancer Agents 2005; 5: 65-71.
7. Bousquet PF, Paulsen LA, Fondy C, Lipski KM, Loucy KJ, Fondy TP. Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma. Cancer Res 1990; 50: 1431-9.
8. Senderowicz AM, Kaur G, Sainz E, et al. Jasplakinolide's inhibi- tion of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton. J Natl Cancer Inst 1995; 87: 46-51.
9. Bonello TT, Stehn JR, Gunning PW. New approaches to targeting the actin cytoskeleton for chemotherapy. Future Med Chem 2009; 1: 1311-31.
10. Nogales E. Structural insights into microtubule function. Annu Rev Biochem. 2000; 69: 277-302.
11. Mitchison T, Kirschner M. Dynamic instability of microtubule growth. Nature 1984; 312: 237-42.
12. Desai A and Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 1997; 13: 83-117.
13. Sharp DJ, Rogers GC and Scholey JM. Microtubule motors in mitosis. Nature 2000; 407: 41-7.
14. Chen J, Liu T, Dong X, Hu Y. Recent development and SAR analysis of colchicine binding site inhibitors. Mini Rev Med Chem 2009; 9: 1174-90.
15. Gidding CE, Kellie SJ, Kamps WA, de Graaf SS. Vincristine revisited. Crit Rev Oncol Hematol 1999; 29: 267-87.
16. De Brabander M, Geuens G, Nuydens R, Willebrords R, De Mey J. Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kineto-chores. Proc Natl Acad Sci USA 1981; 78: 5608-12.
17. Kowalski RJ, Giannakakou P, Hamel E. Activities of the microtu-bule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol®). J Biol Chem 1997; 272: 2534-41.
18. Amos LA, Löwe J. How Taxol stabilises microtubule structure. Chem Biol 1999; 6: R65-9.
19. Alberti C. Taxane- and epothilone-based chemotherapy: from molecule cargo cytoskeletal logistics to management of castration-resistant prostate carcinoma. Eur Rev Med Pharmacol Sci 2013; 17: 1658-64.
20. Muhlradt PF, Sasse F. Epothilone B stabilizes microtubuli of macrophages like taxol without showing taxol-like endotoxin activity. Cancer Res 1997; 57: 3344-6.
21. Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res 1998; 58: 3202-8.
22. Rodi DJ, Janes RW, Sanganee HJ, Holton RA, Wallace BA, Makowski L. Screening of a library of phage-displayed peptides identifies human Bcl-2 as a taxol-binding protein. J MolBiol 1999; 285: 197-203.
23. Harmsen S, Meijerman I, Beijnen JH, Schellens JH. Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor. Cancer Chemother Pharmacol 2009; 64: 35-43.
24. McGrogan BT, Gilmartin B, Carney DN, McCann A. Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta 2008; 1785: 96-132.
25. Goymer P. Natural selection: The evolution of cancer. Nature 2008; 454: 1046-8.
26. Gatenby R. Perspective: Finding cancer's first principles. Nature 2012; 491: S55.
27. Navin N, Kendall J, Troge J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011; 472: 90-4.
28. Greaves M, Maley CC. Clonal evolution in cancer. Nature 2012; 481: 306-13.
29. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013; 339: 1546-58.
30. Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB. Mechanisms of Taxol resistance related to microtubules. Oncogene 2003; 22: 7280–95.
31. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48-58.
32. Chen Z, Ma L, Liu Y, Chen C. Applications of functionalized fullerenes in tumor theranostics. Theranostics 2012; 2: 238-50.
33. Schroeder A, Heller DA, Winslow MM, et al. Treating metastatic cancer with nanotechnology. Nat Rev Cancer 2012; 12: 39-50.
34. (Editorial) Cancer nanotechnology: Small, but heading for the big time. Nat Rev Drug Discov 2007; 6: 174-5.
35. Farokhzad OC, Cheng J, Teply BA, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. PNAS USA 2006; 103: 6315-20.
36. Sailor MJ, Park JH. Hybrid nanoparticles for detection and treatment of cancer. Adv Mater 2012; 24: 3779-802.
37. Dobson, J. Cancer therapy: Death by magnetism. Nat Mat 2012; 11: 1006-8.
38. Bourzac, K. Nanotechnology: Carrying drugs. Nature 2012; 491: S58-60.
39. Bae KH, Chung HJ, Park TG. Nanomaterials for cancer therapy and imaging. Mol Cells 2011; 4: 295-302.
40. Madani SY, Naderi N, Dissanayake O, Tan A, Seifalian AM. A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomed 2011; 6: 2963-79.
41. Yang K, Zhang S, Zhang G, Lee ST, Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. NanoLett 2010; 10: 3318-23.
42. Muller J, Decordier I, Hoet PH, et al. Clastogenic and aneugenic effects of multi-wall CNTs in epithelial cells. Carcinogenesis 2008; 29: 427-433.
43. Cveticanin J, Joksic G, Leskovac A, Petrovic S, Sobot AV, Neskovic O. Using carbon nanotubes to induce micronuclei and double strand breaks of the DNA in human cells. Nanotechnology 2010; 21: 015102.
44. Di Giorgio ML, Di Bucchianico S, Ragnelli AM, Aimola P, San-tucci S, Poma A. Effects of single and multiwalled CNTs on macrophages: Cyto and genotoxicity and electron microscopy. Mu-tat Res 2011; 722: 20-31.
45. Sargent LM, Shvedova AA, Hubbs AF, et al. Induction of ane-uploidy by single-walled carbon nanotubes. Environ Mol Mutagen 2009; 50: 708-17.
46. Sargent LM, Hubbs AF, Young SH, et al. Single-walled carbon nanotube-induced mitotic disruption. Mutat Res 2012; 745: 28-37.
47. Gonzalez L, Decordier I, Kirsch-Volders M. Induction of chromosome malsegregation by nanomaterials. Biochem Soc Trans 2010; 38: 1691-7.
48. Kisin ER, Murray AR, Sargent L, et al. Genotoxicity of carbon nanofibers: are they potentially more or less dangerous than CNTs or asbestos?. Toxicol Appl Pharmacol 2011; 252: 1-10.
49. Li X, Peng Y, Qu X. Carbon nanotubes selective destabilization of duplex and triplex DNA and inducing B-A transition in solution. Nucleic Acids Res 2006; 34: 3670-6.
50. Li X, Peng Y, Ren J, Qu X. Carboxyl-modified single-walled CNTs selectively induce human telomerici-motif formation. Proc Natl Acad Sci USA 2006; 103: 19658-63.
51. Bottini M, Bruckner S, NikaK. Multiwalled carbon nanotubes induced T lymphocyte apoptosis. Toxicol Lett 2006; 160: 121-6.
52. Pulskamp K, Diabaté S. CNTs show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminant. Toxicol Lett 2007; 168: 58-74.
53. Madani SY, Mandel A, Seifalian AM. A concise review of carbon nanotube's toxicology. Nano Rev. 2013; 4.
54. Bhattacharya K, Andón FT, El-Sayed R, Fadeel B. Mechanisms of carbon nanotube-induced toxicity: Focus on pulmonary inflammation. Adv Drug Deliv Rev 2013; 65: 2087-97.
55. Poland CA, Duffin R, Kinloch I, Maynard A. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008; 3: 423-8.
56. Schnorr J M, Swager TM. Emerging application of carbon nano-tubes. Chem Mater 2011; 23: 646-57.
57. De Volder MF, Tawfick SH, Baughman RH, Hart AJ. Carbon nanotubes: Present and future commercial applications. Science 2013; 1: 535-9.
58. Mundra RV, Wu X, Sauer J, Dordick JS, Kane RS. Nanotubes in biological applications. Curr Opin Biotechnol 2014; 28: 25-32.
59. Saito N, Haniu H, Usui Y, et al. Safe clinical use of carbon nano-tubes as innovative biomaterials. Chem Rev. 2014; 114: 6040-79.
60. Marchesan S, Prato M. Nanomaterials for (Nano)medicine. ACS Med Chem Lett 2013; 4: 147-9.
61. Fadeel B, Feliu N, Vogt NC, Abdelmonem AM, Parak WJ. Bridge over troubled waters: Understanding the synthetic and biological identities of engineered nanomaterials. WIREs Nanomed Nanobio-technol 2013; 5: 111-29.
62. Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. The big picture on nanomedicine: the state of inves-tigational and approved nanomedicine products. Nanomed 2013; 9: 1-14.
63. Shi X, Von demBussche A, Hurt RH, Kane AB, Gao H. Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. Nat Nanotechnol 2011; 6: 714-9.
64. Lacerda L, Russier J, Pastorin G, et al. Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes. Biomaterials 2012; 33: 3334-43.
65. Porter AE, Gass M, Muller K, Skepper JN, Midgley PA, Welland M. Direct imaging of single-walled CNTs in cells. Nat Nanotech-nol 2007; 2: 713-7.
66. Yehia HN, Draper RK, Mikoryak C, et al. Single-walled carbon nanotube interactions with HeLa cells. J Nanobiotechnol 2007; 5: 8.
67. Raffa V, Cioffani G, Nitodas S, et al. Can the properties of carbon nanotubes influence their internalization by living cells?. Carbon 2008; 46: 1600-10.
68. Holt BD, Short PA, Rape AD, Wang YL, Islam MF, Dahl KN. Carbon nanotubes reorganize actin structures in cells and ex vivo. ACS Nano 2010; 4: 4872-8.
69. Ju L, Zhang G, Zhang X, et al. Proteomic analysis of cellular response induced by multiwalled carbon nanotubes exposure in A549 cells. PLoS One 2014; 9: e84974.
70. Shams H, Holt BD, Mahboobi SH, et al. Actin reorganization through dynamic interactions with single-wall carbon nanotubes. ACS Nano 2014; 8: 188-97.
71. Pampaloni F, Florin EL. Microtubule architecture: inspiration for novel carbon nanotube-based biomimetic materials. Trends Bio-technol 2008; 26: 302-10.
72. Rodríguez-Fernández L, Valiente R, González, G, Villegas JC, Fanarraga ML. Multiwalled carbon nanotubes display microtubule biomimetic properties in vivo, enhancing microtubule assembly and stabilization. ACS Nano 2012; 6: 6614-25.
73. Dinu CZ, Bale SS, Zhu G, Dordick JS. Tubulin encapsulation of carbon nanotubes into functional hybrid assemblies. Small 2009; 5: 310-5.
74. García Hevia L, Fernández F, Grávalos C, García A, Villegas JC, Fanarraga ML. Nanotube interactions with microtubules: implications for cancer medicine. Nanomedicine 2014; 9: 1581-8.
75. Nagai H, Okazaki Y, Chew SH, et al. Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc Natl Acad Sci USA. 2011; 108: 1330-8.
76. Hamilton RF Jr, Wu Z, Mitra S, Shaw PK, Holian A. Effect of MWCNT size, carboxylation, and purification on in vitro and in vivo toxicity, inflammation and lung pathology. Part Fibre Toxicol 2013; 13: 10-57.
77. Park S, Srivastava D, Cho K. Generalized chemical reactivity of curved surfaces: Carbon nanotubes. NanoLett 2003; 3: 1273-7.
78. Jiang Y, Zhang H, Wang Y, Chen M, Ye S, Hou Z, Ren L. Modulation of apoptotic pathways of macrophages by surface-functionalized multiwalled carbon nanotubes. PLoS One 2013; 8: e65756.
79. Ding L, Stilwell J, Zhang T, et al. Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. NanoLett. 2005; 5: 2448-64.
80. Wang J, Sun P, Bao Y, Liu J, An L. Cytotoxicity of single-walled carbon nanotubes on PC12 cells. Toxicol In Vitro 2011; 25: 242-50.
81. Ye S, Jiang Y, Zhang H, et al. Multiwalled carbon nanotubes induce apoptosis in RAW 264.7 cell-derived osteoclasts through mitochondria-mediated death pathway. J Nanosci Nanotechnol 2012; 12: 2101-12.
82. Wang X, Guo J, Chen T, et al. Multiwalled carbon nanotubes induce apoptosis via mitochondrial pathway and scavenger receptor. Toxicol In Vitro 2012; 26: 799-806.
83. C.S. Sharma, S. Sarkar, A. Periyakaruppan, et al. Single-walled carbon nanotubes induces oxidative stress in rat lung epithelial cells. J Nanosci Nanotechnol 2007; 7: 2466-72.
84. Villegas JC, Álvarez-Montes L, Rodríguez-Fernández L, González J, Valiente R, Fanarraga ML. Multiwalled carbon nanotubes hinder microglia function interfering with cell migration and phagocytosis. Adv Healthc Mater 2014; 3: 424-32.
85. Dong C, Kashon ML, Lowry D, et al. Exposure to carbon nano-tubes leads to changes in the cellular biomechanics. Adv Healthc Mater 2013; 2:945-51.
86. Huang HC, Shi J, Orth JD, Mitchison TJ. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 2009; 16: 347-58.
87. Biris AS, Boldor D, Palmer J, et al. Nanophotothermolysis of multiple scattered cancer cells with carbon nanotubes guided by time-resolved infrared thermal imaging. J Biomed Opt 2009; 14: 021007.
88. Iancu C, Mocan L. Advances in cancer therapy through the use of carbon nanotube-mediated targeted hyperthermia. Int J Nanomed 2011; 6: 1675-84.
89. Bellucci S, Dinicola S, Coluccia, P, et al. Multiwalled carbon nano-tubes-induced cytotoxic effects on human breast adenocarcinoma cell line. Semiconductor Conference (CAS), IEEE Conf Pub 2012; 1: 37-42.
90. Alarifi S, Ali D, Verma A, Almajhdi FN, Al-Qahtani AA. Single-walled carbon nanotubes induce cytotoxicity and DNA damage via reactive oxygen species in human hepatocarcinoma cells. In Vitro Cell Dev Biol Anim 2014; 50: 714-22.
91. Roda E, Castoldi A, Coccini, T, et al. In vitro toxicity assessment of single- and multiwalled carbon nanotubes in human astrocytoma and lung carcinoma cells. Toxicol Lett 2007; 172S:S235.
92. Vittorio O, Raffa V, Cuschieri A. Influence of purity and surface oxidation on cytotoxicity of multiwalled carbon nanotubes with human neuroblastoma cells. Nanomedicine. 2009; 5: 424-31.
93. Han YG, Xu J, Li ZG, Ren GG, Yang Z. In vitro toxicity of multi-walled carbon nanotubes in C6 rat glioma cells. Neurotoxicology. 2012; 33: 1128-34
94. Mooney E, Dockery P, Greiser U, Murphy M, Barron V. CNTs and mesenchymal stem cells: biocompatibility, proliferation and differentiation. NanoLett 2008; 8: 2137-43.
95. Chin SF, Baughman RH, Dalton AB, et al. Amphiphilic helical peptide enhances the uptake of single-walled CNTs by living cells. Exp Biol Med 2007; 232: 1236-44.
96. Malarkey EB, Parpura V. CNTs in neuroscience. Acta Neurochir Suppl 2010; 106: 337-41.
97. Ryoo SR, Kim YK, Kim MH, Min DH. Behaviors of NIH-3T3 fibroblasts on graphene/carbon nanotubes: proliferation, focal adhesion, and gene transfection studies. ACS Nano 2010; 4: 6587-98.
98. Lobo AO, Antunes EF, Machado AHA, Pacheco-Soares C, Trava-Airoldia VJ, Corata EJ. Cell viability and adhesion on as-grown multi-wall carbon nanotube films. Mater Sci Eng C 2007; 28: 264-9.
99. Ravichandran P, Baluchamy S, Gopikrishnan R, et al. Pulmonary biocompatibility assessment of inhaled single-wall and multiwall carbon nanotubes in BALB/c mice. J Biol Chem 2011; 286: 29725-33.
100. Van Berlo D, Wilhelmi V, Boots AW, et al. Apoptotic, inflammatory, and fibrogenic effects of two different types of multiwalled carbon nanotubes in mouse lung. Arch Toxicol 2014; 88: 1725-37.
101. Ali-Boucetta H, Nunes A, Sainz R, et al. Asbestos-like pathogenic-ity of long carbon nanotubes alleviated by chemical functionaliza-tion. Angew Chem Int Ed Engl 2013; 52: 2274-8.
102. Antunes EF, Lobo AO, Corat EJ, Trava-Airoldia VJ, Martin AA, Veríssimo C. Comparative study of first- and second-order Raman spectra of MWCNT at visible and infrared laser excitation. Carbon 2006; 44: 2202-11.
103. Dresselhaus S, Dresselhaus G, Saito R, Jorio A. Raman spectros-copy of carbon nanotubes. Phys Rep 2005; 409: 47-99.
104. Du J, Ge C, Liu Y, et al. The interaction of serum proteins with carbon nanotubes depend on the physicochemical properties of nanotubes. J Nanosci Nanotechnol 2011; 11: 10102-10.
105. Ge C, Du J, Zhao L, et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci USA 2011; 108: 16968-73.
106. Xie HR, Hu LS, Li GY. SH-SY 5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin Med J (Engl) 2010; 20: 1086-92.
107. Clark MJ, Homer N, O'Connor BD, et al. U87 MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. PLoS Genet 2010; 6: e1000832.
108. Ruiz-Ontañon P, Orgaz JL, Aldaz B, et al. Cellular plasticity confers migratory and invasive advantages to a population of glioblas-toma-initiating cells that infiltrate peritumoral tissue. Stem Cells 2013; 31: 1075-85.
109. Grobosch T, Schwarze B, Felgenhauer N, Riesselmann B, Roscher S, Binscheck T. Eight cases of fatal and non-fatal poisoning with Taxus baccata. Forensic Sci Int. 2013; 227: 118-26.
110. Grobosch T, Schwarze B, Stoecklein D, Binscheck T. Fatal poisoning with Taxus baccata: quantification of paclitaxel (taxol A), 10-deacetyltaxol, baccatin III, 10-deacetylbaccatin III, cephaloman-nine (taxol B), and 3,5-dimethoxyphenol in body fluids by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2012; 36: 36-43.